Understanding the Question
This question asks you to identify the
most specific indicator of
diabetic nephropathy (DN) among the listed laboratory findings. The key word here is "specific." While several options indicate poor diabetes control or acute complications, only one directly reflects the kidney damage characteristic of DN.
Analyzing the Options
Let's examine each option through the lens of diabetic nephropathy pathophysiology.
Option 1: Blood glucose level of 380 mg/dL
Hyperglycemia is the primary metabolic derangement in diabetes and the direct cause of the current
diabetic ketoacidosis (DKA) episode. However, it is a marker of the underlying disease and acute decompensation, not a specific indicator of chronic kidney damage. Many patients with severe hyperglycemia have normal renal function, and conversely, DN can progress even with relatively controlled glucose. This finding lacks specificity for nephropathy.
Option 2: Urine albumin excretion of 45 mg over 24 hours
This is the correct answer. A urine albumin excretion between
30 and 300 mg/24 hours defines
microalbuminuria. This is the earliest clinically detectable sign of diabetic nephropathy in a routine setting. The pathophysiological basis is glomerular damage. Chronic hyperglycemia leads to structural changes in the glomerular basement membrane, including thickening and loss of the negative charge barrier, which normally repels negatively charged albumin molecules. This allows albumin to leak into the filtrate. As noted in the provided research, conventional indicators like urinary albumin excretion are central to the clinical diagnosis of DN, even though they often signify that significant structural damage has already occurred
[2]. A study on novel biomarkers also used albuminuria status (normoalbuminuria, microalbuminuria, macroalbuminuria) as the gold standard for staging DN, reinforcing its role as the defining clinical indicator
[3]. This finding is highly specific because it directly reflects a functional deficit in the kidney's filtration apparatus.
Option 3: Hemoglobin A1C level of 10.2%
An elevated
HbA1c reflects the average blood glucose concentration over the preceding 2-3 months. This value indicates chronic, poorly controlled diabetes, which is a major risk factor for developing microvascular complications like nephropathy, retinopathy, and neuropathy. However, it is a marker of risk and glycemic control, not a direct indicator of the presence or severity of kidney damage. A patient can have a high HbA1c without nephropathy, making this finding non-specific.
Option 4: Positive urine ketone test result
Ketonuria is a hallmark of DKA, resulting from accelerated lipolysis and ketogenesis due to an absolute or relative insulin deficiency. It confirms the acute complication the patient is currently experiencing. While DKA can cause transient renal function changes due to osmotic diuresis and dehydration, a positive ketone test has no direct relationship with the chronic structural damage of diabetic nephropathy.
Deep Dive into Diabetic Nephropathy Diagnosis
The clinical diagnosis of diabetic nephropathy is traditionally based on the detection of persistently elevated urinary albumin excretion, which is what this question tests. The research you've been provided highlights a critical nuance: by the time microalbuminuria is detected, significant, and potentially irreversible, glomerular injury has already occurred
[2]. This has spurred the search for earlier biomarkers.
One study investigated
urinary neutrophil gelatinase-associated lipocalin (NGAL), a protein released from injured renal tubular epithelial cells. The study's premise is that tubular injury may actually precede glomerular damage in diabetic kidney disease, making NGAL a potential early indicator of renal injury before albuminuria appears
[2]. Another study examined
urinary podocalyxin, a protein from the podocytes (cells that wrap around glomerular capillaries). Elevated levels of podocalyxin in the urine are associated with podocyte detachment and damage, correlating with DN severity and renal function decline, even in patients with and without albuminuria
[3].
These advanced biomarkers represent the frontier of early detection. However, for the NCLEX-RN and current standard clinical practice, the
24-hour urine albumin excretion remains the cornerstone, most specific, and widely used laboratory indicator for screening and diagnosing diabetic nephropathy. A value of
45 mg/24h confirms the diagnosis of incipient nephropathy, moving beyond mere risk assessment.
References (research sources)
- [2]
Urinary neutrophil Gelatinase-Associated lipocalin as an early and reliable biomarker of diabetic nephropathy in type 2 diabetes mellitus.Research articleYousief E, Adam IH, Ramzy TA, Laymouna A. (2026) · DOI: 10.1016/j.jcte.2026.100441
- [3]
Utility of urinary podocalyxin levels in patients with and without type 2 diabetic nephropathy and its correlation with renal function.Research articlePerumal J, Mehalingam V, Ramasamy R. (2026) · DOI: 10.1186/s13104-026-07724-7